Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies.
Kostine M, Briaire-de Bruijn IH, Cleven AHG, Vervat C, Corver WE, Schilham MW, Van Beelen E, van Boven H, Haas RL, Italiano A, Cleton-Jansen AM, Bovée JVMG. Kostine M, et al. Among authors: van boven h, van beelen e. Oncoimmunology. 2017 Oct 26;7(2):e1386828. doi: 10.1080/2162402X.2017.1386828. eCollection 2018. Oncoimmunology. 2017. PMID: 29308311 Free PMC article.
A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities.
Haas RL, Gelderblom H, Sleijfer S, van Boven HH, Scholten A, Dewit L, Borst G, van der Hage J, Kerst JM, Nout RA, Hartgrink HH, de Pree I, Verhoef C, Steeghs N, van Coevorden F. Haas RL, et al. Among authors: van boven hh, van der hage j, van coevorden f. Acta Oncol. 2015;54(8):1195-201. doi: 10.3109/0284186X.2015.1037404. Epub 2015 Apr 29. Acta Oncol. 2015. PMID: 25920360 Clinical Trial.
Time dependent dynamics of wound complications after preoperative radiotherapy in Extremity Soft Tissue Sarcomas.
Lansu J, Groenewegen J, van Coevorden F, van Houdt W, van Akkooi ACJ, van Boven H, van de Sande M, Verheij M, Haas RL. Lansu J, et al. Among authors: van akkooi acj, van houdt w, van coevorden f, van boven h, van de sande m. Eur J Surg Oncol. 2019 Apr;45(4):684-690. doi: 10.1016/j.ejso.2018.09.001. Epub 2018 Oct 6. Eur J Surg Oncol. 2019. PMID: 30316565
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial.
Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL. Lansu J, et al. Among authors: van der hage ja, van houdt wj, van werkhoven e, van der graaf wta, van coevorden f, van boven h, van den ende pla. JAMA Oncol. 2021 Jan 1;7(1):e205865. doi: 10.1001/jamaoncol.2020.5865. Epub 2021 Jan 21. JAMA Oncol. 2021. PMID: 33180100 Free PMC article. Clinical Trial.
Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas.
Lansu J, van Houdt WJ, van Langevelde K, van den Ende PLA, van der Graaf WTA, Schrage Y, van Boven H, Scholten AN, Haas RL. Lansu J, et al. Among authors: van langevelde k, van houdt wj, van der graaf wta, van boven h, van den ende pla. Radiother Oncol. 2021 May;158:33-39. doi: 10.1016/j.radonc.2021.02.013. Epub 2021 Feb 19. Radiother Oncol. 2021. PMID: 33610624 Clinical Trial.
Corrigendum to "Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas" [Radiother. Oncol. 158 (2021) 33-39].
Lansu J, van Houdt WJ, van Langevelde K, van den Ende PLA, van der Graaf WTA, Schrage Y, van Boven H, Scholten AN, Haas RL. Lansu J, et al. Among authors: van langevelde k, van houdt wj, van der graaf wta, van boven h, van den ende pla. Radiother Oncol. 2021 Oct;163:245. doi: 10.1016/j.radonc.2021.05.018. Epub 2021 Jul 6. Radiother Oncol. 2021. PMID: 34243980 No abstract available.
Propranolol monotherapy in angiosarcoma - A window-of-opportunity study (PropAngio).
Embaby A, Heinhuis KM, IJzerman NS, Koenen AM, van der Kleij S, Hofland I, van Boven H, Sanders J, van der Graaf WTA, Haas RL, Huitema ADR, van Houdt WJ, Steeghs N. Embaby A, et al. Among authors: van boven h. Eur J Cancer. 2024 May;202:113974. doi: 10.1016/j.ejca.2024.113974. Epub 2024 Mar 2. Eur J Cancer. 2024. PMID: 38452721
77 results